相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease
E. M. Toledo et al.
MOLECULAR PSYCHIATRY (2010)
Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model
Luis Escribano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Greasing the wheels of A beta clearance in Alzheimer's Disease: The role of lipids and apolipoprotein E
Jianjia Fan et al.
BIOFACTORS (2009)
Imaging Microglial Activation During Neuroinflammation and Alzheimer's Disease
Sriram Venneti et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice
William J. Meilandt et al.
JOURNAL OF NEUROSCIENCE (2009)
Systemic inflammation and disease progression in Alzheimer disease
C. Holmes et al.
NEUROLOGY (2009)
Hematoma Resolution as a Therapeutic Target The Role of Microglia/Macrophages
Xiurong Zhao et al.
STROKE (2009)
STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's β-amyloid deposits
Gonzalo I. Cancino et al.
BRAIN (2008)
Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist
Nektaria Nicolakakis et al.
JOURNAL OF NEUROSCIENCE (2008)
ApoE promotes the proteolytic degradation of Aβ
Qingguang Jiang et al.
NEURON (2008)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Biochemical and functional characterization of three activated macrophage populations
Justin P. Edwards et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Model organisms - Drug discovery in dementia: the role of rodent models
Debby Van Dam et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Troglitazone, a peroxisome proliferator-activated receptor-γ agonist, decreases tau phosphorylation in CHOtau4R cells
Cristina d'Abramo et al.
JOURNAL OF NEUROCHEMISTRY (2006)
PPARγ as a therapeutic target in central nervous system diseases
Sophia Sundararajan et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Opposing effects of AMPA and 5-HT1A receptor blockade on passive avoidance and object recognition performance:: Correlation with AMPA receptor subunit expression in rat hippocampus
L. Schiapparelli et al.
NEUROPHARMACOLOGY (2006)
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Ward A. Pedersen et al.
EXPERIMENTAL NEUROLOGY (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease
AR Simard et al.
NEURON (2006)
Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ
M Sastre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases
Frauke Zipp et al.
TRENDS IN NEUROSCIENCES (2006)
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone - A preliminary study
GS Watson et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2005)
Role of peroxisome proliferator-activated receptor γ in amyloid precursor protein processing and amyloid β-mediated cell death
C d'Abramo et al.
BIOCHEMICAL JOURNAL (2005)
DNA labeling in living cells
RM Martin et al.
CYTOMETRY PART A (2005)
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice
MT Heneka et al.
BRAIN (2005)
Peroxisome proliferator-activated receptor γ induces a clearance mechanism for the amyloid-β peptide
IE Camacho et al.
JOURNAL OF NEUROSCIENCE (2004)
A modified β-amyloid hypothesis:: intraneuronal accumulation of the β-amyloid peptide -: the first step of a fatal cascade
O Wirths et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Spatial memory, recognition memory, and the hippocampus
NJ Broadbent et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
MA Leissring et al.
NEURON (2003)
Microarray analysis of peroxisome proliferator-activated receptor γ-induced changes in gene expression in macrophages
CP Hodgkinson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease
BA in 't Veld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease
GE Landreth et al.
NEUROBIOLOGY OF AGING (2001)
Behavioral tests of hippocampal function: simple paradigms complex problems
R Gerlai
BEHAVIOURAL BRAIN RESEARCH (2001)
Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma:: Suppression leads to biochemical and pathological deposition
N Iwata et al.
NATURE MEDICINE (2000)